Rochester, Minn.-based Mayo Clinic unveiled partnerships with two artificial intelligence-driven companies Jan. 8 with plans to accelerate personalized medicine capabilities and offerings.
The health system signed an agreement with Cerebras, a team of AI experts, and expanded its relationship with Techcyte, an AI-based digital pathology company.
Mayo Clinic selected Cerebras as its first generative AI collaborator for large-scale, domain-specific AI capabilities for more personalized diagnosis and treatment plans. The Silicon Valley startup is working with Mayo to develop models that will be able to summarize medical records, identify patterns in medical images and analyze genome data, according to Reuters.
"It's an honor to collaborate with Mayo Clinic, a top-ranked hospital in the nation," Andrew Feldman, CEO and co-founder of Cerebras, said in a statement on the company's website. "With its recognized leadership in delivering medical outcomes, we are uniquely positioned to combine AI and medicine. The state-of-the-art AI models we are developing together will work alongside doctors to help with patient diagnosis, treatment planning and outcome estimation."
Mr. Feldman told Reuters his company signed a "multimillion-dollar" agreement with Mayo for a partnership that will last "several years" and Cerebras will provide the health system with hardware and software development services.
Mayo Clinic Platform, the health system's innovation ecosystem, also announced a new partnership with Techcyte. The partners aim to create a digital pathology platform with open, end-to-end, AI-driven solutions for more accurate treatment. Healthcare organizations will be able to use the AI workflow solutions developed through the collaboration to digitize their pathology practices.
Techcyte already collaborates with Mayo to digitize diagnostic testing and lab medicine; now the partners will develop a software as a service-based digital pathology platform that integrates pathologists, LIS vendors, whole slide scanner manufacturers, storage, AI providers, biopharma and labs.
"Mayo Clinic puts the needs of the patient first. That inspires us to innovate, discovering new cures and testing new care models across the many domains of medicine," John Halamka, MD, president of Mayo Clinic Platform, said in a Jan. 8 news release. "Our collaboration with Techcyte will produce a global digital pathology platform, bringing together privacy-protected data sources, solution developers and caregivers."